Up to date, only a few people have heard or have a slight understanding of what sleep apnea is. Most people don’t even know have it as they think it is a normal thing that occur some times. However, a little research shows the relationship between sleep apnea and serious conditions like heart diseases and diabetes. Dr. Avi Weisfogel, a trained dentist has dedicated his career in finding the cure for the condition and to share his findings in order to help other physicians treat it.
Amred with his research and an exyensive knowledge of the condition, Dr Avi founded the Dental Sleep Masters, an organization whose main purpose is to research on the illness and treat it. With his team of qualified physicians and staff, Dr Avi came up with a model and oral applications that are administered to patients with sleep apnea to help them get adequate sleep.
Dr Avi, whose knowledge in marketing knows no bounds has used his skill to enlighten other dentists about the disorder. He has presented his models and his findings to professions in the industry that have helped him market his product. The results he has presented have made it easy for his model to become acceptable and are now being used all over the country and learn more about Avi.
Prior to founding Dental Sleep Master, Dr Avi, founder of Owner Unlimited Sleep Patient was one of the chief lecturers at the institution. The organization was intended to teach dentists on how to diagnose and treat sleep apnea. He led the dentists and his students to developing programs that were used to treat sleep apnea and shared his knowledge with them. All of which have been well received and accepted and contact him.
Dr Avi Weisfogel is passionate about treating the illness. With years of experience treating and researching the disease, patients are confident in his service. He has dedicated his career in helping people recover from sleep apnea and encourages them to live more fulfilling and happy lives. Besides serving people and his community, Dr Avi is a great sports fan. He enjoys skiing and spending time with his family and read full article.
Scott. M. Rocklage has been a managing partner of 5 AM Ventures since 2004, where he had joined the previous year as a venture partner. With over two decades’ experience in healthcare management and his imperative leadership skills, Dr. Scott has led to FDA approval of three new U.S. drug applications (Omniscan™, Teslascan®, and Cubicin®).
Dr. Scott. M. Rocklage currently based in the Waltham, Ma office, acquired his B.S in Chemistry from University of California, Berkeley. He got his Ph.D. from the University of Massachusetts Institute of Technology (MIT) where he did research in the lab of Richard R. Schrock, an award winner in the field of chemistry, 2005.
Dr. Rocklage had held various positions in the healthcare industry. He was once the head and CEO of Cubist Pharmaceuticals and Nycomed Salutar. In addition, he led Nycomed Inventional as president, CEO and Chairman. Dr. Scott explored various R$D positions at Salutar and Catalytica. He also worked at Ilypsa(obtained by Amgen) and Miikana (obtained by EntreMed) as the prime chairman.
Dr. Scott has played a significant role in the invention of over 30 U.S. patents. He has significant peer-reviewed publications to more than a hundred and resume him.
Dr. Rocklage is currently the board chairman of Achaogen, Relypsa and Semprus. He also chairs other organization boards like Waverx, Pulmatrix and Variation. He is also the chairman of the Whitehead Institute Board of Associates and Scott’s lacrosse camp.
In a nutshell
Dr. Rocklage has made tremendous evolutions in the healthcare management systems around the U.S. He has indeed brought to the table what most organizations aspire to have and learn more about Scott.
Brad Reifler is an entrepreneur that has started three companies. After obtaining his Bachelors degree in Economics and Political Science from Bowdoin College, he went on to found and serve as Chief Executive Officer of his company Reifler Trading Company. In 1995 he founded Pali Capital, where he was Chairman and CEO. His latest venture is Forefront Income Trust, where he is the Chief Executive Officer.
The goal that Brad Reifler has with Forefront Income Trust is to help regular people “turn money into more money”. Brad has stated that he used to only focus on high net worth individuals, and founded Forefront Income Trust with the intent to help middle class people save and invest. When his elderly father in law asked Brad to manage his investments, Brad was surprised to learn that because the father in law wasn’t an accredited investor there were lucrative strategies that he was locked out of. There are specialty finance programs that to date have only been available to the richest 1% and Brad wants to make these programs available to everyone.
In this fund, Brad Reifler gives an opportunity to middle class people to invest in these strategies with a minimum of $2,500. The investments are not correlated to the stock market and so gives the investor greater diversity versus just holding stocks and bonds. Brad has also structured the fund so that his company earns nothing until their clients make an 8% return on their investment.
Brad Reifler has explained that there are three main problems that middle class investors face. The first is that they face fees that not only are far too high but that also make money for the brokers regardless of their performance. The second is that most people are not allowed to participate in some investments, unlike the richest of us. The third is that regular investors have far too much risk as most of their money is exposed to the ups and downs of the stock markets. His goal with Forefront Income Trust is to change all three of these factors.